Dudediligence.

Krystal Biotech, Inc

KRYSNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$94.6M

19 notices · 330,806 sh

Oct 2025 to Oct 2026

Reported ·

$78.7M

107 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

105 of 107 reported sales carry the 10b5-1 box. Together they are 1.03% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-04: SUMA KRISHNAN, Form 1442026-09-04: KRISH KRISHNAN, Form 1442026-08-14: Dino A. Rossi, Form 1442026-06-25: Thomas John Charles, Form 1442026-06-04: SUMA KRISHNAN, Form 1442026-06-04: KRISH KRISHNAN, Form 1442026-05-26: Thomas John Charles, Form 1442026-03-04: SUMA KRISHNAN, Form 1442026-03-04: KRISH KRISHNAN, Form 1442026-03-02: ROMANO KATHRYN, Form 1442026-02-27: Daniel S Janney, Form 1442026-02-26: Daniel S Janney, Form 1442026-02-25: Daniel S Janney, Form 1442026-02-24: JANNEY DANIEL, Form 1442026-02-24: Daniel S Janney, Form 1442026-02-19: ROSSI DINO A, Form 1442026-02-09: ROMANO KATHRYN, Form 1442025-12-04: KRISH KRISHNAN, Form 1442025-12-04: SUMA KRISHNAN, Form 1442025-12-04: Krishnan Krish S, sold2025-12-04: Krishnan Suma, sold2026-02-09: ROMANO KATHRYN, sold2026-02-19: ROSSI DINO A, sold2026-02-24: JANNEY DANIEL, sold2026-02-27: JANNEY DANIEL, sold2026-03-02: ROMANO KATHRYN, sold2026-03-04: Krishnan Krish S, sold2026-03-04: Krishnan Suma, sold2026-05-26: Thomas John Charles, sold2026-06-04: Krishnan Krish S, sold2026-06-04: Krishnan Suma, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-04SUMA KRISHNAN, President, R&D$9,286,750
25,000 shplan 2025-09-04Form 4s on file end Jun 23144 ↗
2026-09-04KRISH KRISHNAN, President and CEO$9,286,750
25,000 shplan 2025-09-04Form 4s on file end Jun 23144 ↗
2026-08-14Dino A. Rossi, Director$8,306,750
25,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-25Thomas John Charles, EVP, General Counsel$347,270
1,000 shplan 2026-02-23144 ↗
Form 4, 2026-06-26: sold 1,000 at $347.27 Form 4 ↗
2026-06-04SUMA KRISHNAN, President, R&D$7,545,500
25,000 shplan 2025-09-04144 ↗
Form 4, 2026-06-05: sold 25,000 at $308.12 Form 4 ↗
2026-06-04KRISH KRISHNAN, President and CEO$7,545,500
25,000 shplan 2025-09-04144 ↗
Form 4, 2026-06-05: sold 25,000 at $308.12 Form 4 ↗
2026-05-26Thomas John Charles, EVP, General Counsel$193,903
642 shplan 2026-02-23144 ↗
Form 4, 2026-05-27: sold 642 at $302.03 Form 4 ↗
2026-03-04SUMA KRISHNAN, President, R&D$6,595,000
25,000 shplan 2025-09-04144 ↗
Form 4, 2026-03-06: sold 25,000 at $263.21 Form 4 ↗
2026-03-04KRISH KRISHNAN, President and CEO$6,595,000
25,000 shplan 2025-09-04144 ↗
Form 4, 2026-03-06: sold 25,000 at $263.17 Form 4 ↗
2026-03-02ROMANO KATHRYN, Chief Accounting Officer$200,700
750 shplan 2025-11-06144 ↗
Form 4, 2026-03-03: sold 750 at $267.60 Form 4 ↗
2026-02-27Daniel S Janney, Director$3,252,824
11,803 shplan 2025-11-25144 ↗
Form 4, 2026-03-03: sold 11,803 at $275.59 Form 4 ↗
2026-02-26Daniel S Janney, Director$2,133,680
7,741 shplan 2025-11-25no Form 4 on file144 ↗
2026-02-25Daniel S Janney, Director$192,500
700 shplan 2025-11-25no Form 4 on file144 ↗
2026-02-24JANNEY DANIEL, Director$10.1M
37,895 shplan 2025-11-25144 ↗
Form 4, 2026-02-26: sold 60,161 at $268.44 Form 4 ↗
2026-02-24Daniel S Janney, Director$3,709,850
13,825 shplan 2025-11-25no Form 4 on file144 ↗
2026-02-19ROSSI DINO A, Director$4,953,694
18,950 shno plan date144 ↗
Form 4, 2026-02-23: sold 18,950 at $261.41 Form 4 ↗
2026-02-09ROMANO KATHRYN, Chief Accounting Officer$3,458,250
12,500 shplan 2025-11-06144 ↗
Form 4, 2026-02-11: sold 12,500 at $272.14 Form 4 ↗
2025-12-04KRISH KRISHNAN, President and CEO$5,436,500
25,000 shplan 2025-09-04144 ↗
Form 4, 2025-12-05: sold 50,000 at $220.15 Form 4 ↗
2025-12-04SUMA KRISHNAN, President, R&D$5,436,500
25,000 shplan 2025-09-04144 ↗
Form 4, 2025-12-05: sold 50,000 at $220.15 Form 4 ↗